Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising.
Helen W SullivanAmie C O'DonoghueKathryn J AikinRyan S PaquinKate Ferriola-BruckensteinPublished in: The oncologist (2023)
Disclosures could help reduce the extent to which people misinterpret endpoints like ORR and PFS. More research is needed to establish best-practice recommendations for using disclosures to improve patient understanding of drug efficacy without changing their perception of the drug in unintended ways.